 | • レポートコード：MRC23Q38334 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場について調査・分析し、世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（プロトオンコジーン c Src、Pp60c src、SRC、EC 2.7.10.2）、用途別セグメント分析（腫瘍学、呼吸器、中枢神経系、消化器、遺伝性疾患、感染症、筋骨格系疾患、眼科）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、AbbVie Inc、AstraZeneca Plc、Avalyn Pharma Inc、Boehringer Ingelheim International GmbH、KeifeRx LLC、Lead Discovery Center GmbH、Taiwan Liposome Co Ltd、TopiVert Ltd、Turning Point Therapeutics Incなどが含まれています。世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、プロトオンコジーンチロシンプロテインキナーゼSrc市場規模を推定する際に考慮しました。本レポートは、プロトオンコジーンチロシンプロテインキナーゼSrcの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、プロトオンコジーンチロシンプロテインキナーゼSrcに関するビジネス上の意思決定に役立てることを目的としています。 ・プロトオンコジーンチロシンプロテインキナーゼSrc市場の概要 - 製品の定義 - プロトオンコジーンチロシンプロテインキナーゼSrcのタイプ別セグメント - 世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模：タイプ別分析（プロトオンコジーン c Src、Pp60c src、SRC、EC 2.7.10.2） - プロトオンコジーンチロシンプロテインキナーゼSrcの用途別セグメント - 世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模：用途別分析（腫瘍学、呼吸器、中枢神経系、消化器、遺伝性疾患、感染症、筋骨格系疾患、眼科） - 世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模予測（2018年-2029年） - プロトオンコジーンチロシンプロテインキナーゼSrcの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - プロトオンコジーンチロシンプロテインキナーゼSrc市場の競争状況およびトレンド ・プロトオンコジーンチロシンプロテインキナーゼSrcの地域別市場規模 - 北米のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - アメリカのプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - ヨーロッパのプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - アジア太平洋のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - 中国のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - 日本のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - 韓国のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - インドのプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - オーストラリアのプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - 中南米のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） - 中東・アフリカのプロトオンコジーンチロシンプロテインキナーゼSrc市場規模（2018年-2029年） ・タイプ別セグメント：プロトオンコジーン c Src、Pp60c src、SRC、EC 2.7.10.2 - 世界のプロトオンコジーンチロシンプロテインキナーゼSrcのタイプ別販売量（2018年-2023年） - 世界のプロトオンコジーンチロシンプロテインキナーゼSrcのタイプ別売上（2018年-2023年） - 世界のプロトオンコジーンチロシンプロテインキナーゼSrcのタイプ別価格 ・用途別セグメント：腫瘍学、呼吸器、中枢神経系、消化器、遺伝性疾患、感染症、筋骨格系疾患、眼科 - 世界のプロトオンコジーンチロシンプロテインキナーゼSrcの用途別販売量（2018年-2023年） - 世界のプロトオンコジーンチロシンプロテインキナーゼSrcの用途別売上（2018年-2023年） - 世界のプロトオンコジーンチロシンプロテインキナーゼSrcの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 AbbVie Inc、AstraZeneca Plc、Avalyn Pharma Inc、Boehringer Ingelheim International GmbH、KeifeRx LLC、Lead Discovery Center GmbH、Taiwan Liposome Co Ltd、TopiVert Ltd、Turning Point Therapeutics Inc ・産業チェーンと販売チャネルの分析 - プロトオンコジーンチロシンプロテインキナーゼSrc産業チェーン分析 - プロトオンコジーンチロシンプロテインキナーゼSrcの主要原材料 - プロトオンコジーンチロシンプロテインキナーゼSrcの販売チャネル - プロトオンコジーンチロシンプロテインキナーゼSrcのディストリビューター - プロトオンコジーンチロシンプロテインキナーゼSrcの主要顧客 ・プロトオンコジーンチロシンプロテインキナーゼSrc市場ダイナミクス - プロトオンコジーンチロシンプロテインキナーゼSrcの業界動向 - プロトオンコジーンチロシンプロテインキナーゼSrc市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Proto Oncogene Tyrosine Protein Kinase Src(Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2)pipeline Target constitutes close to 20 molecules.Out of which approximately 18 molecules are developed by companies and remaining by the universities/institutes.The latest report Proto Oncogene Tyrosine Protein Kinase Src–Drugs In Development,2021,outlays comprehensive information on the Proto Oncogene Tyrosine Protein Kinase Src(Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2)targeted therapeutics,complete with analysis by indications,stage of development,mechanism of action (MoA),route of administration (RoA) and molecule type.
Highlights
The global Proto Oncogene Tyrosine Protein Kinase Src market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Proto Oncogene Tyrosine Protein Kinase Src is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Proto Oncogene Tyrosine Protein Kinase Src is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Proto Oncogene Tyrosine Protein Kinase Src include AbbVie Inc, AstraZeneca Plc, Avalyn Pharma Inc, Boehringer Ingelheim International GmbH, KeifeRx LLC, Lead Discovery Center GmbH, Taiwan Liposome Co Ltd, TopiVert Ltd and Turning Point Therapeutics Inc, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Proto Oncogene Tyrosine Protein Kinase Src, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proto Oncogene Tyrosine Protein Kinase Src.
The Proto Oncogene Tyrosine Protein Kinase Src market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Proto Oncogene Tyrosine Protein Kinase Src market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Proto Oncogene Tyrosine Protein Kinase Src manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AbbVie Inc
AstraZeneca Plc
Avalyn Pharma Inc
Boehringer Ingelheim International GmbH
KeifeRx LLC
Lead Discovery Center GmbH
Taiwan Liposome Co Ltd
TopiVert Ltd
Turning Point Therapeutics Inc
Segment by Type
Proto Oncogene c Src
Pp60c src
SRC
EC 2.7.10.2
Segment by Application
Oncology
Respiratory
Central Nervous System
Gastrointestinal
Genetic Disorders
Infectious Disease
Musculoskeletal Disorders
Ophthalmology
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Proto Oncogene Tyrosine Protein Kinase Src manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Proto Oncogene Tyrosine Protein Kinase Src in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Proto Oncogene Tyrosine Protein Kinase Src Market Overview
1.1 Product Overview and Scope of Proto Oncogene Tyrosine Protein Kinase Src
1.2 Proto Oncogene Tyrosine Protein Kinase Src Segment by Type
1.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Market Value Comparison by Type (2023-2029)
1.2.2 Proto Oncogene c Src
1.2.3 Pp60c src
1.2.4 SRC
1.2.5 EC 2.7.10.2
1.3 Proto Oncogene Tyrosine Protein Kinase Src Segment by Application
1.3.1 Global Proto Oncogene Tyrosine Protein Kinase Src Market Value by Application: (2023-2029)
1.3.2 Oncology
1.3.3 Respiratory
1.3.4 Central Nervous System
1.3.5 Gastrointestinal
1.3.6 Genetic Disorders
1.3.7 Infectious Disease
1.3.8 Musculoskeletal Disorders
1.3.9 Ophthalmology
1.4 Global Proto Oncogene Tyrosine Protein Kinase Src Market Size Estimates and Forecasts
1.4.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue 2018-2029
1.4.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales 2018-2029
1.4.3 Global Proto Oncogene Tyrosine Protein Kinase Src Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Proto Oncogene Tyrosine Protein Kinase Src Market Competition by Manufacturers
2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Manufacturers (2018-2023)
2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Proto Oncogene Tyrosine Protein Kinase Src Average Price by Manufacturers (2018-2023)
2.4 Global Proto Oncogene Tyrosine Protein Kinase Src Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Proto Oncogene Tyrosine Protein Kinase Src, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Proto Oncogene Tyrosine Protein Kinase Src, Product Type & Application
2.7 Proto Oncogene Tyrosine Protein Kinase Src Market Competitive Situation and Trends
2.7.1 Proto Oncogene Tyrosine Protein Kinase Src Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Proto Oncogene Tyrosine Protein Kinase Src Players Market Share by Revenue
2.7.3 Global Proto Oncogene Tyrosine Protein Kinase Src Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Proto Oncogene Tyrosine Protein Kinase Src Retrospective Market Scenario by Region
3.1 Global Proto Oncogene Tyrosine Protein Kinase Src Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Proto Oncogene Tyrosine Protein Kinase Src Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region: 2018-2029
3.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region: 2018-2023
3.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region: 2024-2029
3.3 Global Proto Oncogene Tyrosine Protein Kinase Src Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region: 2018-2029
3.3.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region: 2018-2023
3.3.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region: 2024-2029
3.4 North America Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
3.4.1 North America Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2018-2029)
3.4.3 North America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
3.5.1 Europe Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2018-2029)
3.5.3 Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
3.6.1 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2018-2029)
3.6.3 Asia Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
3.7.1 Latin America Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2018-2029)
3.7.3 Latin America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Market Facts & Figures by Country
3.8.1 Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2018-2029)
3.8.3 Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2018-2029)
4.1.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2018-2023)
4.1.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2024-2029)
4.1.3 Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2018-2029)
4.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2018-2029)
4.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2018-2023)
4.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2024-2029)
4.2.3 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2018-2029)
4.3 Global Proto Oncogene Tyrosine Protein Kinase Src Price by Type (2018-2029)
5 Segment by Application
5.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2018-2029)
5.1.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2018-2023)
5.1.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2024-2029)
5.1.3 Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2018-2029)
5.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2018-2029)
5.2.1 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2018-2023)
5.2.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2024-2029)
5.2.3 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2018-2029)
5.3 Global Proto Oncogene Tyrosine Protein Kinase Src Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Corporation Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 AstraZeneca Plc
6.2.1 AstraZeneca Plc Corporation Information
6.2.2 AstraZeneca Plc Description and Business Overview
6.2.3 AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
6.2.5 AstraZeneca Plc Recent Developments/Updates
6.3 Avalyn Pharma Inc
6.3.1 Avalyn Pharma Inc Corporation Information
6.3.2 Avalyn Pharma Inc Description and Business Overview
6.3.3 Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
6.3.5 Avalyn Pharma Inc Recent Developments/Updates
6.4 Boehringer Ingelheim International GmbH
6.4.1 Boehringer Ingelheim International GmbH Corporation Information
6.4.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.4.3 Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
6.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.5 KeifeRx LLC
6.5.1 KeifeRx LLC Corporation Information
6.5.2 KeifeRx LLC Description and Business Overview
6.5.3 KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2018-2023)
6.5.4 KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
6.5.5 KeifeRx LLC Recent Developments/Updates
6.6 Lead Discovery Center GmbH
6.6.1 Lead Discovery Center GmbH Corporation Information
6.6.2 Lead Discovery Center GmbH Description and Business Overview
6.6.3 Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
6.6.5 Lead Discovery Center GmbH Recent Developments/Updates
6.7 Taiwan Liposome Co Ltd
6.6.1 Taiwan Liposome Co Ltd Corporation Information
6.6.2 Taiwan Liposome Co Ltd Description and Business Overview
6.6.3 Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
6.7.5 Taiwan Liposome Co Ltd Recent Developments/Updates
6.8 TopiVert Ltd
6.8.1 TopiVert Ltd Corporation Information
6.8.2 TopiVert Ltd Description and Business Overview
6.8.3 TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2018-2023)
6.8.4 TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
6.8.5 TopiVert Ltd Recent Developments/Updates
6.9 Turning Point Therapeutics Inc
6.9.1 Turning Point Therapeutics Inc Corporation Information
6.9.2 Turning Point Therapeutics Inc Description and Business Overview
6.9.3 Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Product Portfolio
6.9.5 Turning Point Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Proto Oncogene Tyrosine Protein Kinase Src Industry Chain Analysis
7.2 Proto Oncogene Tyrosine Protein Kinase Src Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Proto Oncogene Tyrosine Protein Kinase Src Production Mode & Process
7.4 Proto Oncogene Tyrosine Protein Kinase Src Sales and Marketing
7.4.1 Proto Oncogene Tyrosine Protein Kinase Src Sales Channels
7.4.2 Proto Oncogene Tyrosine Protein Kinase Src Distributors
7.5 Proto Oncogene Tyrosine Protein Kinase Src Customers
8 Proto Oncogene Tyrosine Protein Kinase Src Market Dynamics
8.1 Proto Oncogene Tyrosine Protein Kinase Src Industry Trends
8.2 Proto Oncogene Tyrosine Protein Kinase Src Market Drivers
8.3 Proto Oncogene Tyrosine Protein Kinase Src Market Challenges
8.4 Proto Oncogene Tyrosine Protein Kinase Src Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer